US Stock MarketDetailed Quotes

MTSR Metsera

Watchlist
  • 27.490
  • -1.010-3.54%
Close Mar 4 16:00 ET
  • 27.490
  • 0.0000.00%
Post 16:48 ET
2.83BMarket Cap-16.73P/E (TTM)

About Metsera Company

Metsera, Inc. is a clinical stage biopharmaceutical company, which engages in the development of a next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. Its product pipeline includes MET-097i, MET-233, and MET-224o. The company was founded by Clive A. Meanwell on June 29, 2022 and is headquartered in New York, NY.

Company Profile

SymbolMTSR
Company NameMetsera
Listing DateJan 31, 2025
Issue Price18.00
Founded2022
CEOMr. Christopher Whitten Bernard
MarketNASDAQ
Fiscal Year Ends12-31
Address3 World Trade Center,175 Greenwich Street
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10007
Phone1-212-784-6595

Company Executives

  • Name
  • Position
  • Salary
  • Christopher Whitten Bernard
  • President, Chief Executive Officer and Director
  • 5.73M
  • Christopher J. Visioli
  • Chief Business Officer and Chief Financial Officer
  • 2.85M
  • Dr. Steven Marso, M.D.
  • Chief Medical Officer
  • --
  • Dr. Brian Hubbard, Pd.D
  • Chief Scientific Officer
  • 1.02M
  • Gbola Amusa, M.D.
  • Executive Vice President, Strategic Finance and Investor Relations
  • 1.62M
  • Dr. Clive A. Meanwell, M.D.,PhD
  • Executive Chairman of the Board
  • 1.80M
  • Kristina M. Burow
  • Independent Director
  • 445.75K
  • Paul L. Berns
  • Independent Director
  • 1.27M
  • Dr. Joshua Pinto, PhD
  • Independent Director
  • 445.75K
Trending Stocks
Donald Trump Donald Trump

Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump. Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump.